Katie Lafferty has served as the Executive Director of the CSN since 2001. In addition to overseeing the operations of the CSN, Ms. Lafferty has led the CSN through the inception of the Canadian Stroke Strategy in 2003, a successful renewal of NCE funding in 2005, and the development of the Canadian Stroke Congress, beginning in 2010. Since 2006, Ms. Lafferty has also served as co-owner of Watson’s Pharmacy and Compounding Centre, an independent pharmacy in Ottawa, Ontario. In 2010, Ms. Lafferty was recognized as one of Ottawa’s Top Forty Under 40 for her leadership in the Canadian health sector. Prior to joining the CSN, Ms. Lafferty was a Principal Consultant with PricewaterhouseCoopers in Washington D.C. and London, England, serving a wide range of private and public sector clients. Ms. Lafferty has served on local community Boards of Directors, has made regular appearances on local TV, and is currently a member of the Board of Directors and chair of the Audit and Finance Committee of the Canadian Public Health Association. Ms. Lafferty holds a BSc in biology from Queen’s University and an MBA from Carnegie Mellon University in Pittsburgh, Pennsylvania.